Holen Sie sich die Stockscreener-App
133.75
1.04%
-1.393
Handel nachbörslich:
132.54
-1.207
-0.90%
Schlusskurs vom Vortag:
$135.14
Offen:
$134.15
24-Stunden-Volumen:
601.78K
Relative Volume:
0.82
Marktkapitalisierung:
$8.11B
Einnahmen:
$4.09B
Nettoeinkommen (Verlust:
$-404.84M
KGV:
-19.82
EPS:
-6.7469
Netto-Cashflow:
$1.24B
1W Leistung:
-2.61%
1M Leistung:
+6.01%
6M Leistung:
+31.44%
1J Leistung:
+20.45%
1-Tages-Spanne:
$132.41
$136.06
1-Wochen-Bereich:
$132.41
$139.44
52-Wochen-Spanne:
$95.49
$148.06
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Firmenname
Jazz Pharmaceuticals Plc
Sektor
Branche
Telefon
353-1-634-7800
Adresse
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Vergleichen Sie JAZZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
133.75 | 8.20B | 4.09B | -404.84M | 1.24B | -6.7469 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Eingeleitet | Deutsche Bank | Buy |
| 2025-03-07 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Eingeleitet | Goldman | Buy |
| 2024-01-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-11-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-06-12 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2022-12-09 | Hochstufung | Goldman | Neutral → Buy |
| 2022-06-14 | Eingeleitet | UBS | Buy |
| 2022-04-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-11-19 | Fortgesetzt | Goldman | Buy |
| 2021-10-07 | Fortgesetzt | Jefferies | Buy |
| 2021-10-05 | Eingeleitet | Citigroup | Buy |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-05-19 | Fortgesetzt | JP Morgan | Overweight |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-02-05 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-11-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-14 | Herabstufung | Goldman | Neutral → Sell |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Eingeleitet | Goldman | Neutral |
| 2019-08-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2018-12-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2018-11-08 | Bestätigt | B. Riley FBR | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2018-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Bestätigt | H.C. Wainwright | Neutral |
| 2018-03-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
Why Jazz Pharmaceuticals plc stock is seen as undervaluedMarket Risk Analysis & Risk Controlled Swing Alerts - newser.com
When is the best time to exit Jazz Pharmaceuticals plc2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
Callan Family Office LLC Buys New Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Is Jazz Pharmaceuticals plc stock a buy before product launches2025 Technical Overview & Safe Capital Growth Tips - newser.com
Is Jazz Pharmaceuticals plc stock attractive for passive investors2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
Jazz Pharmaceuticals plc stock outlook for YEARPortfolio Growth Summary & Weekly High Return Stock Forecasts - newser.com
Order flow analysis tools used on Jazz Pharmaceuticals plcJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
What institutional flow reveals about Jazz Pharmaceuticals plcPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Is Jazz Pharmaceuticals plc showing signs of accumulation2025 Technical Overview & Technical Pattern Alert System - newser.com
Jazz Pharmaceuticals plc’s volatility index tracking explained2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com
Will Jazz Pharmaceuticals plc benefit from macro trendsGap Up & Free Reliable Trade Execution Plans - newser.com
Forecasting Jazz Pharmaceuticals plc price range with options dataEarnings Growth Report & Stepwise Swing Trade Plans - newser.com
How strong is Jazz Pharmaceuticals plc stock revenue growthEntry Point & Low Drawdown Trading Strategies - newser.com
Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 38% Upside Potential with Robust Analyst Support - DirectorsTalk Interviews
Q3 EPS Forecast for Jazz Pharmaceuticals Reduced by Analyst - MarketBeat
Full technical analysis of Jazz Pharmaceuticals plc stockWeekly Volume Report & Smart Money Movement Alerts - newser.com
Published on: 2025-10-12 20:45:57 - newser.com
Assessing Jazz Pharmaceuticals (JAZZ) Valuation Following Strong Recent Share Price Momentum - Yahoo Finance
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Meritage Portfolio Management - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by KLP Kapitalforvaltning AS - MarketBeat
Jazz Pharmaceuticals (JAZZ): Assessing Valuation Following Recent Net Income Growth and Share Price Recovery - simplywall.st
Zacks Research Has Positive Forecast for JAZZ Q2 Earnings - MarketBeat
Lmcg Investments LLC Lowers Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Cannabis Market Trends and Company Analysis 2025-2033 Featuring Canopy Growth, Tilray Brands, Curaleaf, Aurora, Jazz Pharma, Green Thumb Industries, Trulieve, Cresco Labs, Organigram, TerrAscend - Yahoo Finance
United States Idiopathic Hypersomnia Treatment Market: Jazz Pharmaceuticals & Emerging Competitors - openPR.com
Leerink Partnrs Has Bearish Estimate for JAZZ Q3 Earnings - MarketBeat
Jazz Pharmaceuticals (JAZZ) Receives a Buy from Truist Financial - The Globe and Mail
Jazz Pharmaceuticals (JAZZ) Gets a Buy from Bank of America Securities - The Globe and Mail
Will Jazz Pharmaceuticals plc stock keep outperforming rivalsBuy Signal & Safe Capital Growth Plans - newser.com
BofA Adjusts Price Target on Jazz Pharmaceuticals Public to $230 From $225 - MarketScreener
Weiss Ratings Reiterates "Sell (D)" Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ) - MarketBeat
Is Jazz Pharmaceuticals plc a candidate for recovery playMarket Trend Review & High Conviction Buy Zone Picks - newser.com
Tick level data insight on Jazz Pharmaceuticals plc volatility2025 Year in Review & High Accuracy Trade Alerts - newser.com
Lewy Body Dementia Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Jazz Pharma, Allergan, Noven Pharma, Takeda Pharma, Eli Lilly, Mallinckrodt Pharma - Barchart.com
Roche Wins FDA Nod for Label Expansion of Tecentriq in Lung Cancer - Yahoo Finance
Will Jazz Pharmaceuticals plc (J7Z) stock remain on Wall Street radarTake Profit & Long-Term Capital Growth Strategies - newser.com
Will Jazz Pharmaceuticals plc (J7Z) stock announce special dividend - newser.com
What MACD and RSI say about Jazz Pharmaceuticals plc2025 Biggest Moves & Real-Time Sentiment Analysis - newser.com
Are Shares of Jazz Pharmaceuticals Set for Growth After Strong Q2 Results in 2025? - simplywall.st
Why Jazz Pharmaceuticals plc (J7Z) stock could be top winnerQuarterly Profit Summary & High Accuracy Investment Entry Signals - newser.com
Robeco Institutional Asset Management B.V. Sells 92,794 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):